-: For me, it's that we're actually
impacting patients' lives.
So what we're doing, I mean, basic science
is really important, but it's really exciting
to be a part of sort of impacting patients
and making a real difference in their lives.
So a lot of the patients in our trials
are heavily pre-treated, they've tried everything.
And it's really exciting to see patients
actually having clinical responses,
prolonged clinical responses
based on work that our lab has developed
and agents that we've developed.
In my role, it's challenging to keep up
with a rapidly changing field.
Things in immunotherapy are now very hot.
There's agents that are being approved
and also failing in trials.
So just to keep up with that,
I mean that impacts what we can do moving forward as well.
So just sort of trying to keep up
with a rapidly changing field
and also rapidly changing priorities.
You kind of have to stop things
and focus your attention in other areas
and sometimes it's hard to let go of something
that you've worked a long time on
to refocus on something else.